Cárdenas-VargasA, Elizondo-QuirogaD, Gutierrez-OrtegaA, et al.Evaluation of the immunogenicity of a potyvirus-like particle as an adjuvant of a synthetic peptide. Viral Immunol, 2016; 29:557–564.
2.
HashimASM, AboshanabKMA, and El-SayedAFM. Developing an inactivated rotavirus vaccine and evaluating the immunogenicity against a commercially available attenuated rotavirus vaccine using a mice animal model. Viral Immunol, 2016; 29:565–571.
3.
NegiN, VajpayeeM, SinghR, et al.Cross-reactive potential of HIV-1 subtype C-infected Indian individuals against multiple HIV-1 potential T cell epitope Gag variants. Viral Immunol, 2016; 29:572–582.
4.
PachoS, DadouhE, MerinoJ, et al.Assessment of a novel vaccine against rabbit hemorrhagic disease virus in young rabbits. Viral Immunol, 2016; 29:583–585.
5.
PiñeyroPE, SubramaniamS, KenneySP, et al.Modulation of proinflammatory cytokines in monocyte-derived dendritic cells by porcine reproductive and respiratory syndrome virus through interaction with the porcine intercellular-adhesion-molecule-3-grabbing nonintegrin. Viral Immunol, 2016; 29:546–556.
6.
RehmanSU, RaufM, AbbasZ, et al.Role of some predominant host immunomodulators' single nucleotide polymorphisms in severity of hepatitis B virus and hepatitis C virus infection. Viral Immunol, 2016; 29:536–545.
